Your browser doesn't support javascript.
loading
Mechanistic understanding of the role of ATRX in senescence provides new insight for combinatorial therapies with CDK4 inhibitors.
Kovatcheva, Marta; Klein, Mary E; Tap, William D; Koff, Andrew.
Affiliation
  • Kovatcheva M; Louis V. Gerstner Graduate School of Biomedical Science and the Program in Molecular Biology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA.
  • Klein ME; Louis V. Gerstner Graduate School of Biomedical Science and the Program in Molecular Biology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA.
  • Tap WD; Department of Medicine, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA.
  • Koff A; Louis V. Gerstner Graduate School of Biomedical Science and the Program in Molecular Biology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA.
Mol Cell Oncol ; 5(1): e1384882, 2018.
Article in En | MEDLINE | ID: mdl-29404388
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Cell Oncol Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Cell Oncol Year: 2018 Document type: Article Affiliation country: United States Country of publication: United States